TetraGraph to Evaluate Onset and Recovery Times of Rocuronium
NCT: NCT07435792 · ENROLLING_BY_INVITATION
Brief Summary
In most clinical instances, direct laryngoscopy and endotracheal intubation is performed after a set time (generally 60 seconds) following the administration of a neuromuscular (NM) blocking agent, rocuronium. Although the average onset time is 60 seconds, clinical studies show a standard deviation around the mean onset time of 10-20 seconds, meaning that a significant number of patients do not achieve complete NM blockade by 60 seconds. Given the above noted variability, complete NM blockade may not be achieved in 60 seconds in a significant percentage of patients, resulting in more problematic direct laryngoscopy and endotracheal intubation. Various studies have shown a higher incidence of perioperative respiratory events and postoperative concerns (sore throat, vocal cord injury) when NM blockade is not complete prior to endotracheal intubation. This study aims to use the TetraGraph monitor to clearly identify onset times of rocuronium. Additionally, whenever feasible based on the clinical needs of the case, recovery times after the single dose of rocuronium will be recorded.
Frequently Asked Questions
What is TetraGraph to Evaluate Onset and Recovery Times of Rocuronium?
TetraGraph to Evaluate Onset and Recovery Times of Rocuronium is a clinical trial registered under NCT07435792. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07435792?
The current status of NCT07435792 (TetraGraph to Evaluate Onset and Recovery Times of Rocuronium) is: ENROLLING_BY_INVITATION.
When did TetraGraph to Evaluate Onset and Recovery Times of Rocuronium start?
TetraGraph to Evaluate Onset and Recovery Times of Rocuronium started on 2026-08-25.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.